Navana Pharmaceuticals PLC (DSE:NAVANAPHAR)
58.80
+0.20 (0.34%)
At close: May 6, 2026
6.72% (1Y)
| Market Cap | 6.32B +20.0% |
| Revenue (ttm) | 10.07B +26.3% |
| Net Income | 609.04M +44.4% |
| EPS | 5.65 +43.8% |
| Shares Out | 107.42M |
| PE Ratio | 10.41 |
| Forward PE | n/a |
| Dividend | 1.40 (2.39%) |
| Ex-Dividend Date | Nov 20, 2025 |
| Volume | 377,154 |
| Average Volume | 445,755 |
| Open | n/a |
| Previous Close | 58.60 |
| Day's Range | 58.40 - 59.60 |
| 52-Week Range | 45.50 - 65.80 |
| Beta | 0.06 |
| RSI | 50.33 |
| Earnings Date | Jan 28, 2026 |